Screener
Madrigal Pharmaceuticals, Inc. MDGL Invested capital
Discontinued — last reported Q2 '26
Invested capital at other companies
Other financials
Where this comes from
Calculated from Madrigal Pharmaceuticals, Inc.’s reported figures.
The source filing: Madrigal Pharmaceuticals, Inc.’s 10-Q, filed July 30, 2026. Open the filing →
- Filed
- Jul 30, 2026, 9:06 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-050845
FAQ
- What is Madrigal Pharmaceuticals, Inc.'s invested capital?
- Madrigal Pharmaceuticals, Inc. (MDGL) reported invested capital of $608.69M in Q2 2026.
- How has Madrigal Pharmaceuticals, Inc.'s invested capital changed year-over-year?
- Madrigal Pharmaceuticals, Inc.'s invested capital decreased by 4.9% year-over-year, from $640.34M to $608.69M.
- What is the long-term trend for Madrigal Pharmaceuticals, Inc.'s invested capital?
- Over 5 years (2020 to 2025), Madrigal Pharmaceuticals, Inc.'s invested capital has grown at a 31.9% compound annual growth rate (CAGR), from $186.75M to $746.54M.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).
Ask your AI about Madrigal Pharmaceuticals, Inc.'s invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude